MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

28 Jul 2022 Evaluate
The sales moved up 42.61% to Rs. 235.06 millions for the June 2022 quarter as compared to Rs. 164.83 millions during the year-ago period.Net profit declined -6.60% to Rs. 22.94 millions from Rs. 24.56 millions.Operating profit for the quarter ended June 2022 decreased to 38.42 millions as compared to 41.65 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 235.06 164.83 42.61 235.06 164.83 42.61 750.74 607.51 23.58
Other Income 1.53 0.37 313.51 1.53 0.37 313.51 1.84 1.89 -2.65
PBIDT 38.42 41.65 -7.76 38.42 41.65 -7.76 164.39 162.02 1.46
Interest 0.47 0.33 42.42 0.47 0.33 42.42 4.54 6.42 -29.28
PBDT 37.95 41.32 -8.16 37.95 41.32 -8.16 159.85 175.46 -8.90
Depreciation 7.30 8.04 -9.20 7.30 8.04 -9.20 32.81 28.19 16.39
PBT 30.65 33.28 -7.90 30.65 33.28 -7.90 127.04 147.27 -13.74
TAX 7.71 8.72 -11.58 7.71 8.72 -11.58 34.88 31.15 11.97
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 1.43 -2.46 -158.13
PAT 22.94 24.56 -6.60 22.94 24.56 -6.60 92.16 116.12 -20.63
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 61.52 100.02
PBIDTM(%) 16.34 25.27 -35.32 16.34 25.27 -35.32 21.90 26.67 -17.89
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..